tiprankstipranks
Grupo Financiero Galicia SA (GGAL)
NASDAQ:GGAL
Holding GGAL?
Track your performance easily

Grupo Financiero Galicia SA (GGAL) Income Statement

773 Followers

Grupo Financiero Galicia SA Income Statement

Last quarter (Q4 2023), Grupo Financiero Galicia SA's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, Grupo Financiero Galicia SA's net income was $―. See Grupo Financiero Galicia SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 71.26B$ 3.51T$ -692.50B$ -158.88B$ 306.91B$ 207.51B
Credit Losses Provision
$ -2.90B---$ -50.31B$ -30.23B
Non Interest Expense
$ 38.15B$ 2.97T$ 194.50B$ 142.02B$ 135.17B$ 94.85B
Incomefrom Associatesand Other Participating Interests
$ -55.00M--$ 31.09B$ -188.76M$ 0.00
Special Income Charges
$ -16.08B$ -2.59T$ 48.64B$ -23.26B$ 0.00$ 9.68B
Pretax Income
$ 14.07B$ 543.01B$ 65.64B$ 47.50B$ 69.88B$ 50.18B
Tax Provision
$ 4.66B$ 205.84B$ 17.00B$ 16.41B$ 31.37B$ 17.75B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 9.41B$ 337.17B$ -904.00B$ -317.31B$ 37.99B$ 32.28B
Basic EPS
$ 63.80$ 228.64$ 32.98$ 21.09$ 174.60$ 166.20
Diluted EPS
$ 63.80$ 228.64$ 32.98$ 21.09$ 174.60$ 166.20
Basic Average Shares
$ 147.47M$ 1.47B$ 1.47B$ 1.47B$ 144.27M$ 142.68M
Diluted Average Shares
$ 147.47M$ 1.47B$ 27.41B$ 15.05B$ 144.27M$ 142.68M
Dividend Per Share
----$ 5.91$ 13.67
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----$ 466.18M$ 135.79M
Interest Income After Provision For Loan Loss
$ 23.48B$ 1.74T$ -564.38B$ -180.89B$ 64.88B$ 16.68B
Net Income From Continuing And Discontinued Operation
$ 9.41B$ 337.17B$ -904.00B$ -317.31B$ 37.99B$ 32.28B
Normalized Income
$ 20.16B$ 553.45B--$ 37.99B$ 26.02B
Total Money Market Investments
----$ 13.38B$ 9.72B
Ebit
------
Ebitda
------
Currency in ARS

Grupo Financiero Galicia SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis